Pathophysiology of osteoarthritis: Evidence against the viscoelastic theory

Pathobiology

Volumn 76, Issue 6, 2009, Pages 322-328

  Dunn, Sharon ^a   Kolomytkin, Oleg V ^b   Marino, Andrew A ^b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Louisiana State University Health Sciences Center at Shreveport   (United States)

Author keywords

Hyaluronan; Osteoarthritis; Synovial fluid; Viscoelasticity

Indexed keywords

HYALURONIC ACID;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL ELECTROPHORESIS; GEL PERMEATION CHROMATOGRAPHY; HUMAN; MOLECULAR WEIGHT; NEEDLE BIOPSY; OSTEOARTHRITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REFRACTOMETRY; SYNOVIAL FLUID; VISCOELASTICITY;

ADULT; AGED; AGED, 80 AND OVER; CHROMATOGRAPHY, GEL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; HYALURONIC ACID; MIDDLE AGED; MOLECULAR WEIGHT; OSTEOARTHRITIS, KNEE; SYNOVIAL FLUID; VISCOELASTIC SUBSTANCES; YOUNG ADULT;

EID: 72449207614     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000245898     Document Type: Article

References (34)

1. Hootman JM, Helmick CG: Projections of US prevalence of arthritis and associated activity limitations. Arthritis Rheum 2006; 54: 226-229.
2. Insall JN, Scott WN: Surgery of the Knee, ed 3. New York, Churchill Livingstone, 2001.
3. Jones A, Doherty M: Intra-articular therapies in osteoarthritis; in Brandt KD, Doherty M, Lohmander LS (eds): Osteoarthritis. Oxford, Oxford Press, 1998, pp 299-306.
4. Jüni P, Reichenbach S, Trelle S, Tschannen B, Wandel S, Jordi B, Züllig M, Guetg R, Häuselmann HJ, Schwarz H, Theiler R, Ziswiler HR, Dieppe PA, Villiger PM, Egger M, Swiss Viscosupplementation Trial Group: Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee. A randomized controlled trial. Arthritis Rheum 2007; 56: 3610-3619.
5. Mathieu P, Conrozier T, Vignon E, Rozand Y, Rinaudo M: Rheologic behavior of osteoarthritic synovial fluid after addition of hyaluronic acid. A pilot study. Clin Orthop Relat Res DOI: 10.1007/s11999-11009-10867-x.
6. Strauss EJ, Hart JA, Miller MD, Altman RD, Rosen JE: Hyaluronic acid viscosupplementation and osteoarthritis. Current uses and future directions. Am J Sports Med DOI: 10.1177/0363546508326984.
7. Watterson JR, Esdaile JM: Viscosupplementation: Therapeutic mechanisms and clinical potential in osteoarthritis of the knee. J Am Acad Orthop Surg 2000; 8: 277-284.
8. Balazs EA, Watson D, Duff IF, Roseman S: Hyaluronic acid in synovial fluid. I: Molecular parameters of hyaluronic acid in normal and arthritis human fluids. Arthritis Rheum 1967; 10: 357-376.
9. Balazs EA: The physical properties of synovial fluid and the special role of hyaluronic acid; in Helfet AJ (ed): Disorders of the Knee. Philadelphia, J.B. Lippincott Co., 1982, pp 61-74.
10. Balazs EA: Viscosupplementation for treatment of osteoarthritis: From initial discovery to current status and results. Surg Technol Int 2004; 12: 278-289.
11. Balazs EA, Denlinger JL: The role of hyaluronic acid in arthritis and its therapeutic use; in Peyron JG (ed): Osteoarthritis - Current Clinical and Fundamental Problems. Basel, Geigy, 1985, pp 165-174.
12. Balazs EA, Denlinger JL: Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol 1993; 20: 309.
13. Peyron JG, Balazs EA: Preliminary clinical assessment of Na-hyaluronate injection into human arthritic joints. Pathol Biol (Paris) 1974; 22: 731-736.
14. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G: Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2006: CD005321.
15. Itano N: Simple primary structure, complex turnover regulation and multiple roles of hyaluronan. J Biochem 2008; 144: 131-137.
16. Slevin M, Krupinski J, Gaffney J, Matou S, West D, Delisser H, Savani RC, Kumar S: Hyaluronan- mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signalling pathways. Matrix Biol 2007; 26: 58-68.
17. Dunn S, Kolomytkin OV, Waddell DD, Marino AA: Hyaluronan-binding receptors: possible involvement in osteoarthritis. Mod Rheumatol DOI: 10.1007/s10165-008-0136-y.
18. Waddell DD, Kolomytkin OV, Dunn S, Marino AA: Hyaluronan suppresses IL-1-induced metalloproteinase activity from synovial tissue. Clin Orthop 2007; 465: 241-248.
19. Lee HG, Cowman MK: An agarose gel electrophoretic method for analysis of hyaluronan molecular weight distribution. Anal Biochem 1994; 219: 278-287.
20. Baggenstoss BA, Weigel PH: Size exclusion chromatography - multiangle laser light scattering analysis of hyaluronan size distributions maDe by membrane-bound hyaluronan synthase. Anal Biochem 2006; 352: 243-251.
21. Cantor JO, Nadkarni PP: Hyaluronan: The Jekyll and HyDe molecule. Inflamm Allergy Drug Targets 2006; 5: 257-260.
22. Altman RD: Intra-articular sodium hyaluronate in osteoarthritis of the knee. Semin Arthritis Rheum 2000; 30: 11-18.
23. Castor CW, Prince RK, Hazelton MJ: Hyaluronic acid in human synovial effusions; a sensitive indicator of altered connective tissue cell function during inflammation. Arthritis Rheum 1966; 9: 783-794.
24. Dahl LB, Dahl IM, Engström-Laurent A, Granath K: Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 1985; 44: 817-822.
25. Evanich JD, Evanich CJ, Wright MB, Rydlewicz JA: Efficacy of intraarticular hyaluronic acid injections in knee osteoarthritis. Clin Orthop 2001; 390: 173-181.
26. Grimshaw J, Trocha-Grimshaw J, Fisher W, Rice A, Smith S, Spedding P, Duffy J, Mollan R: Quantitative analysis of hyaluronan in human synovial fluid using capillar electrophoresis. Electrophoresis 1996; 17: 396-400.
27. Kofoed J, Tocci AA, Barcelo AC: The acidic glycosaminoglycans of the synovial fluid in rheumatoid arthritis. Experientia 1973; 29: 680-681.
28. Mazzucco MD, Scott R, Spector M: Composition of joint fluid in patients undergoing total knee replacement and revision arthroplasty: correlation with flow properties. Biomaterials 2004; 25: 4433-4445.
29. Miyaguchi M, Kobayashi A, Kadoya Y, Ohashi H, Yamano Y, Takaoka K: Biochemical change in joint fluid after isometric quadriceps exercise for patients with osteoarthritis of the knee. Osteoarthritis Cartilage 2003; 11: 252-259.
30. Nakayama Y, Narita T, Mori A, Uesaka S, Miyazaki K, Ito H: The effects of age and sex on chondroitin sulfates in normal synovial fluid. Arthritis Rheum 2002; 46: 2105-2108.
31. Pitsillides AA, Will RK, Bayliss MT, Edwards JCW: Circulating and synovial fluid hyaluronan levels. Arthritis Rheum 1994; 7: 1030-1038.
32. Saito T, Takeuchi R, Mitsuhashi S, Uesugi M, Yoshida T, Koshino T: Use of joint fluid analysis for determining cartilage damage in osteonecrosis of the knee. Arthritis Rheum 2002; 46: 1813-1819.
33. Uesaka S, Miyazaki K, Ito H: Age-related changes and sex differences in chondroitin sulfate isomers and hyaluronic acid in normal synovial fluid. Mod Rheumatol 2004; 14: 470-475.
34. Carroll GJ: Spectrophotometric measurement of proteoglycans in osteoarthritic synovial fluid. Ann Rheum Dis 1987; 46: 375-379.